Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 10;18(12):15153-81.
doi: 10.3390/molecules181215153.

Extending the glucosyl ceramide cassette approach: application in the total synthesis of ganglioside GalNAc-GM1b

Affiliations

Extending the glucosyl ceramide cassette approach: application in the total synthesis of ganglioside GalNAc-GM1b

Miku Konishi et al. Molecules. .

Abstract

The development of a novel cyclic glucosyl ceramide cassette acceptor for efficient glycolipid syntheses was investigated. p-Methoxybenzyl (PMB) groups were selected as protecting groups at C2 and C3 of the glucose residue with the aim of improving the functionality of the cassette acceptor. The choice of the PMB group resulted in a loss of β-selectivity, which was corrected by using an appropriate tether to control the spatial arrangement and the nitrile solvent effect. To investigate the effect of linker structure on the β-selectivity of intramolecular glycosylation, several linkers for tethering the glucose and ceramide moiety were designed and prepared, namely, succinyl, glutaryl, dimethylmalonyl, and phthaloyl esters. The succinyl ester linker was the best for accessing the cassette form. The newly designed glucosyl ceramide cassette acceptor was then applied in the total synthesis of ganglioside GalNAc-GM1b.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of our previously reported cyclic GlcCer cassette acceptor (left). Structure of newly designed cyclic GlcCer cassette acceptor (right).
Scheme 1
Scheme 1
Synthesis of the 2,3-di-O-PMB-protected glucose derivative.
Scheme 2
Scheme 2
Tethering between the glucose residue and ceramide derivative by various types of dicarboxylate linkers.
Figure 2
Figure 2
Structure of ganglioside GalNAc-GM1b and key disconnections for total synthesis.
Scheme 3
Scheme 3
Synthesis of the non-reducing end glycan sequence of GalNAc-GM1b.
Scheme 4
Scheme 4
Final glycosylation using the GlcCer cassette approach and global deprotection.

References

    1. Sonnino S., Mauri L., Chigorno V., Prinetti A. Gangliosides as components of lipid membrane domains. Glycobiology. 2006;17:1R–13R. doi: 10.1093/glycob/cwl052. - DOI - PubMed
    1. Todeschini A.R., Hakomori S.I. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, Motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta. 2008;1780:421–433. doi: 10.1016/j.bbagen.2007.10.008. - DOI - PMC - PubMed
    1. Lopez P.H., Schnaar R.L. Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 2009;19:549–557. doi: 10.1016/j.sbi.2009.06.001. - DOI - PMC - PubMed
    1. Posse de Chaves E., Sipione S. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett. 2010;584:1748–1759. doi: 10.1016/j.febslet.2009.12.010. - DOI - PubMed
    1. Kusunoki S., Kaida K. Antibodies against ganglioside complexes in Guillain–Barré syndrome and related disorders. J. Neurochem. 2011;116:828–832. doi: 10.1111/j.1471-4159.2010.07029.x. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources